Dr Laura Long Says Pathways Are Part of a Bigger Care Delivery Transformation

Historically, people talk about pathways as if they are an answer, but they are really just one component to cancer care delivery, said Laura Long, MD, MPH, president at TheLongView, PC, and editorial board member for The American Journal of Pharmacy Benefits.

"What [pathways] can do is help reduce variation and help improve the delivery of evidence-based care, but you need to have the rest of the package," she said.

Payment still needs to be aligned with outcomes and the care delivery model needs to become more patient-centered, Dr Long added.